Page 2 - Nasdaq Amph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nordea Investment Management AB trimmed its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% during the third quarter, Holdings Channel.com reports. The fund owned 338,443 shares of the company’s stock after selling 349 shares during the quarter. Nordea Investment Management AB’s holdings in Amphastar Pharmaceuticals were worth $15,700,000 as of […]

StockNews.com cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a buy rating to a hold rating in a research note released on Tuesday. Separately, Bank of America began coverage on shares of Amphastar Pharmaceuticals in a research note on Friday, November 17th. They set a neutral rating and a $63.00 price objective on […]

StockNews.com cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday. Separately, Bank of America began coverage on Amphastar Pharmaceuticals in a research report on Friday, November 17th. They issued a neutral rating and a $63.00 price objective on the […]

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) fell 3.9% during trading on Friday . The company traded as low as $54.15 and last traded at $54.23. 221,672 shares traded hands during trading, a decline of 62% from the average session volume of 577,505 shares. The stock had previously closed at $56.43. Analyst Ratings Changes […]

StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a report released on Friday morning. Separately, Bank of America started coverage on shares of Amphastar Pharmaceuticals in a research report on Friday, November 17th. They issued a neutral rating and a $63.00 price target for […]